Stephanie A. Flowers

Author

University of Michigan ORCID

Also Known As

Flowers, Stephanie, Stephanie A Flowers, Stephanie A. Flowers, Stephanie Flowers, Stephanie A. Flowers

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Michigan University of Tennessee Health Science Center University of Illinois Chicago University of Illinois Urbana-Champaign Swansea University

About

Stephanie A. Flowers is an author at University of Michigan specializing in medicine, microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	727
2	Microbiology	4	4	712
3	Health Sciences	2	2	127
4	Biochemistry	2	2	127
5	Health Informatics	1	1	15

Stephanie A. Flowers

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
The gut microbiome composition associates with bipolar disorder and illness severity Simon J. Evans, Christine M. Bassis, Robert Hein, Journal of Psychiatric Research DysbiosisPsychiatryMicrobiotaGut MicrobiologyIllness Severity	2016	299
Contribution of Clinically Derived Mutations in <i>ERG11</i> to Azole Resistance in Candida albicans Stephanie A. Flowers, Brendan Colón, Sarah Whaley, Antimicrobial Agents and Chemotherapy Clinically Derived MutationsAntifungal AgentAzole ResistanceAntifungal AgentsGenetics	2014	286
Gain-of-Function Mutations in <i>UPC2</i> Are a Frequent Cause of <i>ERG11</i> Upregulation in Azole-Resistant Clinical Isolates of Candida albicans Stephanie A. Flowers, Katherine S. Barker, Elizabeth L. Berkow, Eukaryotic Cell	2012	235
Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort Stephanie A. Flowers, Simon J. Evans, Kristen M. Ward, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2016	229
Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia Stephanie A. Flowers, Nielson T. Baxter, Kristen M. Ward, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2019	100
<i>UPC2</i> Is Universally Essential for Azole Antifungal Resistance in Candida albicans Erin M. Vasicek, Elizabeth L. Berkow, Stephanie A. Flowers, Eukaryotic Cell Azole Antifungal ResistanceMicrobial PathogensFungal Cell BiologyClinical MycologyAntimicrobial Chemotherapy	2014	73
The Evolution of Azole Resistance in <i>Candida albicans</i> Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions Andrew G. S. Warrilow, Andrew T. Nishimoto, Josie E. Parker, Antimicrobial Agents and Chemotherapy Antifungal AgentAzole ResistanceBiochemistryHealth SciencesAntifungal Agents	2019	54
<i>In Vitro</i> Activities of the Novel Investigational Tetrazoles VT-1161 and VT-1598 Compared to the Triazole Antifungals against Azole-Resistant Strains and Clinical Isolates of <i>Candida albicans</i> Andrew T. Nishimoto, Nathan P. Wiederhold, Stephanie A. Flowers, Antimicrobial Agents and Chemotherapy	2019	48
Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers Jamie N. Connarn, Stephanie A. Flowers, Marisa Kelly, The AAPS Journal	2017	29
The Atypical Antipsychotic Quetiapine Promotes Multiple Antibiotic Resistance in Escherichia coli Yasuhiro Kyono, Lori Ellezian, YueYue Hu, Journal of Bacteriology	2022	18

Page 1